Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepatitis A vaccine (virosomal, pediatric dose)
- Development stage
- Phase 4
- Lead developer
- Panacea Biotec
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
HAVpur Junior is a pediatric virosomal hepatitis A vaccine designed to protect against infection by the hepatitis A virus (HAV), a serious liver disease transmitted through contaminated food, water, or person-to-person contact. The vaccine contains inactivated or weakened strains of the virus formulated with virosomes and is administered intramuscularly. It stimulates the immune system to produce antibodies against HAV, providing seroprotection in children as young as 1 year old. Clinical studies have shown that HAVpur Junior induces an immune response comparable to other established pediatric hepatitis A vaccines such as Havrix 720 Junior and is well tolerated with a favorable safety profile. The product does not contain aluminum adjuvant and is suitable for inclusion in childhood vaccination schedules[1][3][4][5].
- Brand names
- HAVpur Junior
- Other names
- HAVpur Juniorvirosomal hepatitis A vaccine (pediatric)low-dose virosomal HAV vaccine
02
Targets
Hepatitis A virus capsid protein
Beyond the preview
Go deeper on Hepatitis A vaccine (virosomal, pediatric dose).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis A vaccine (virosomal, pediatric dose).